Outcome After Laparoscopic Versus Open Pancreaticoduodenectomy
PaMIvOP
1 other identifier
observational
90
0 countries
N/A
Brief Summary
Aim of the study : To determine the morbimortality of Laparoscopic pancreaticoduodenectomy (LPD) compared to the gold standard Open pancreaticoduodenectomy approach (OPD). Methods : This is a monocentric retrospective study based on a prospectively maintained clinical database. The study included 28 consecutive patients operated, between January 2016 and March 2019, of Laparoscopic pancreaticoduodenectomy (LPD) that we compared to 62 patients operated with the classical open approach by the same surgeon before the first laparoscopic resection at our institution.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2016
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedFirst Submitted
Initial submission to the registry
May 6, 2020
CompletedFirst Posted
Study publicly available on registry
May 11, 2020
CompletedMay 12, 2020
May 1, 2020
3.1 years
May 6, 2020
May 10, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Morbimortality of Laparoscopic pancreaticoduodenectomy (LPD)
Morbimortality of Laparoscopic pancreaticoduodenectomy (LPD) compared to the gold standard Open pancreaticoduodenectomy approach (OPD) :Overall morbidity (according to Clavien Dindo Classification)
90 postoperative days
Secondary Outcomes (2)
Number of lymph nodes removed
14 postoperative days
Margins of excision
14 postoperative days
Study Arms (2)
Patients with an open approach
Patients requiring pancreatoduodenectomy and operated with an open approach : All consecutive patients requiring pancreato-duodenectomies for benign or malignant pathology before the first laparoscopic pancreaticoduodenectomy.
Patients with a laparoscopic approach
Patients requiring pancreatoduodenectomy and operated with a laparoscopic approach : All consecutive patients requiring pancreato-duodenectomies for benign or malignant pathology operated with a laparoscopic approach.
Interventions
Open or laparoscopic pancreato-duodenectomy with pancreatojejunal anastomosis
Eligibility Criteria
Patients who had Pancreatoduodenectomy with pancreatojejunal anastomosis whatever the indication
You may qualify if:
- \- Pancreatoduodenectomy with pancreatojejunal anastomosis whatever the indication
You may not qualify if:
- reject the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Montpellierlead
- Université Montpelliercollaborator
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
REGIS SOUCHE
University Hospital, Montpellier
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 6, 2020
First Posted
May 11, 2020
Study Start
August 1, 2016
Primary Completion
September 1, 2019
Study Completion
October 1, 2019
Last Updated
May 12, 2020
Record last verified: 2020-05